Andy Biotech

Drug pricing has been one of the central issues of the 2016 presidential campaign. There is currently a whirlwind of negative public sentiment swirling around controversial pricing practices of companies like Valeant Pharmaceuticals Intl Inc (NYSE: VRX), Mallinckrodt PLC (NYSE: MNK) and Mylan NV (...